323 related articles for article (PubMed ID: 31414922)
1. Pharmacokinetics of oral therapeutics delivered by dendrimer-based carriers.
Yellepeddi VK; Ghandehari H
Expert Opin Drug Deliv; 2019 Oct; 16(10):1051-1061. PubMed ID: 31414922
[No Abstract] [Full Text] [Related]
2. Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
Wijagkanalan W; Kawakami S; Hashida M
Pharm Res; 2011 Jul; 28(7):1500-19. PubMed ID: 21181549
[TBL] [Abstract][Full Text] [Related]
3. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in dendrimer-based nanocarriers.
Bai S; Thomas C; Rawat A; Ahsan F
Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
[TBL] [Abstract][Full Text] [Related]
5. Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.
Sadekar S; Ghandehari H
Adv Drug Deliv Rev; 2012 May; 64(6):571-88. PubMed ID: 21983078
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
7. Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy.
Zhou Z; Ma X; Murphy CJ; Jin E; Sun Q; Shen Y; Van Kirk EA; Murdoch WJ
Angew Chem Int Ed Engl; 2014 Oct; 53(41):10949-55. PubMed ID: 25155439
[TBL] [Abstract][Full Text] [Related]
8. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.
Araújo F; Shrestha N; Granja PL; Hirvonen J; Santos HA; Sarmento B
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):381-93. PubMed ID: 25495133
[TBL] [Abstract][Full Text] [Related]
9. Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole.
Mansuri S; Kesharwani P; Tekade RK; Jain NK
Eur J Pharm Biopharm; 2016 May; 102():202-13. PubMed ID: 26563727
[TBL] [Abstract][Full Text] [Related]
10. Dendrimers for pharmaceutical and biomedical applications.
Yang H; Kao WJ
J Biomater Sci Polym Ed; 2006; 17(1-2):3-19. PubMed ID: 16411595
[TBL] [Abstract][Full Text] [Related]
11. Poly(amido amine) dendrimers in oral delivery.
Yellepeddi VK; Ghandehari H
Tissue Barriers; 2016; 4(2):e1173773. PubMed ID: 27358755
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-dendrimer bioconjugate: a nanotool for therapeutics, diagnosis, and imaging.
Pednekar PP; Jadhav KR; Kadam VJ
Expert Opin Drug Deliv; 2012 Oct; 9(10):1273-88. PubMed ID: 22897588
[TBL] [Abstract][Full Text] [Related]
13. Transepithelial and endothelial transport of poly (amidoamine) dendrimers.
Kitchens KM; El-Sayed ME; Ghandehari H
Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433
[TBL] [Abstract][Full Text] [Related]
14. G5 PAMAM dendrimer versus liposome: a comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatin.
Qi R; Zhang H; Xu L; Shen W; Chen C; Wang C; Cao Y; Wang Y; van Dongen MA; He B; Wang S; Liu G; Banaszak Holl MM; Zhang Q
Nanomedicine; 2015 Jul; 11(5):1141-51. PubMed ID: 25791813
[TBL] [Abstract][Full Text] [Related]
15. Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol.
Chauhan AS
Ann N Y Acad Sci; 2015 Aug; 1348(1):134-40. PubMed ID: 26173478
[TBL] [Abstract][Full Text] [Related]
16. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.
Mignani S; El Kazzouli S; Bousmina M; Majoral JP
Adv Drug Deliv Rev; 2013 Oct; 65(10):1316-30. PubMed ID: 23415951
[TBL] [Abstract][Full Text] [Related]
17. Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability.
Jain NK; Gupta U
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1035-52. PubMed ID: 18680439
[TBL] [Abstract][Full Text] [Related]
18. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
